SEPRAGEN CORP
NT 10-K, 1997-03-31
TOTALIZING FLUID METERS & COUNTING DEVICES
Previous: OXFORD TAX EXEMPT FUND II LTD PARTNERSHIP, NT 10-K, 1997-03-31
Next: EMERGING MARKETS GROWTH FUND INC, 497, 1997-03-31




                             UNITED STATES
                   SECURITIES AND EXCHANGE COMMISSION
                         Washington, D.C. 20549
                              FORM 12b-25
                       NOTIFICATION OF LATE FILING     SEC FILE NUMBER
                                                         0-25726      
  (Check One):
  X Form 10-K     Form 20-F   Form 11-K   Form 10-Q   Form N-SAR

                  For Period Ended: December 31, 1996
                              Transition Report on Form 10-KSB
                              Transition Report on Form 20-F
                              Transition Report on Form 11-K
                              Transition Report on Form 10-Q
                              Transition Report on Form N-SAR

   Nothing in this form shall be construed to imply that the 
Commission has verified any information contained herein.

       If the notification relates to a portion of the filing checked
above, identify the Item(s) to which the notification relates:

  PART I - REGISTRANT INFORMATION

  Full Name of Registrant: SEPRAGEN CORPORATION

  Former Name if Applicable:

  Address of Principal Executive Office (Street and Number):
  Huntwood Drive, Hayward, California 94544                   30689

  PART II-RULES 12B-25(B) AND(C)

  If the subject report could not be filed without unreasonable
  effort or expense and the registrant seeks relief pursuant to Rule
  12b-25(b), the following should be completed. (Check box if appro-
  priate)
       (a)  The reasons described in reasonable detail in Part III of
            this form could not be eliminated without unreasonable
            effort or expense.
   X   
       (b)  The subject annual report, semi-annual report, transition
            report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or
            portion thereof, will be filed on or before the fifteenth
            calendar day following the prescribed due date; or the
            subject quarterly report of transition report on Form 10-
            Q, or portion thereof will be filed on or before the
            fifth calendar day following the prescribed  due date;
            and

       (c)  The Accountant's statement or other exhibit required by
            Rule 12b-25(c) has been attached if applicable.

  Part III - NARRATIVE

  State below in reasonable detail the reasons why Form 10-KSB, 20-F,
  11-K, 10-Q, N-SAR, or the transition report or portion thereof,
  could not be filed within the prescribed time period.

       Due to reduced staff and resources, Registrant was unable to
  complete all accounting and due diligence work for the Report.


  Part IV - Other Information

  (1)  Name and telephone number of person to contact in regard to
       this notification:  Vinit Saxena        (510) 476-0650

  (2)  Have all other periodic reports required under Section 13 or
       15(d) of the Securities Exchange Act of 1934 or Section 30 of
       the Investment Company Act of 1940 during the preceding 12
       months or for such shorter period that the registrant was
       required to file such report(s) been filed?  If answer is no,
       identify report(s):  Yes   X      No      

  (3)  Is it anticipated that any significant change in results of
       operations from the corresponding period for the last fiscal
       year will be reflected by the earnings statements to be in-
       cluded in the subject report or portion thereof?  Yes X  No  

  If so, attach an explanation of the anticipated change, both
  narratively and quantitatively, and, if appropriate, state the
  reasons why a reasonable estimate of the results cannot be made.

                          SEPRAGEN CORPORATION

  has caused this notification to be signed on its behalf by the
  undersigned hereunto duly authorized.

   Date: 3/28/97            By:   /s/ Vinit Saxena                  
                                President and CEO

  The form may be signed by an executive officer of the registrant or
  by any other duly authorized representative.




                          SEPRAGEN CORPORATION           DRAFT 3/28/97

                             BALANCE SHEET

                                 ASSETS
                                            December 31,           
                                           1996               1995 
  Current assets:
      Cash                            $ 217,057        $    23,364 
      Marketable securities                  --          3,586,145 
      Accounts receivable, less
        allowance for doubtful 
        accounts of $10,298 and
        $30,459 as of December 31,
        1996 and 1995, respectively     183,805            278,688 
      Inventories                       474,872            777,620 
      Prepaid expenses and other         12,633             57,130 

         Total current assets           888,367          4,722,947 
  Furniture and equipment, net          388,201            252,150 
  Intangible assets                     130,837            111,709 
                                   $  1,407,425        $ 5,086,806 

             LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIT)

  Current liabilities:
      Accounts payable              $  196,686           $ 230,799 
      Accrued liabilities               67,665             174,395 
      Accrued payroll and benefits     110,967              80,633 
      Interest payable                      --              4,285  
         Total current liabilities     375,318             490,112 
  Commitments:
      Class E common stock, no par 
        value--1,600,000 shares authorized; 
        1,209,894 and 1,111,961 shares
        issued and outstanding at December 31, 
        1996 and 1995; redeemable at 
        $.01 per share                      --                  -- 
  Shareholders' equity (deficit):
      Preferred stock, no par value--
        5,000,000 shares authorized; none
        issued and outstanding at 
        December 31, 1996 and 1995          --                  -- 
      Class A common stock, no par 
        value--20,000,000 shares 
        authorized; 2,149,155 and 
        2,070,000 shares issued and 
        outstanding at December 31, 
        1996 and 1995                8,812,701           8,353,737 
      Class B common stock, no par 
        value--2,600,000 shares 
        authorized; 707,276 and 
        786,431 shares issued and 
        outstanding at December 31, 
        1996 and 1995                4,100,992           4,559,956 
      Net unrealized loss on 
        available-for-sale securities       --             (14,462)
      Accumulated deficit          (11,881,586)         (8,302,537)
        Total shareholders' 
          equity (deficit)           1,032,107          (4,596,694)

                                   $ 1,407,425         $ 5,086,806 
<PAGE>
                          SEPRAGEN CORPORATION           DRAFT 3/28/97

                        STATEMENTS OF OPERATIONS
             for the years ended December 31, 1996 and 1995

                                         For the Years            
                                         Ended December 31,       
                                                 1996        1995

  Revenues:
      Net sales                        $ 1,002,562   $  1,046,256 
  Costs and expenses:
      Cost of goods sold                   840,593        685,291 
      Selling, general, and 
        administrative                   2,344,273      2,280,130 
      Research and development           1,487,231      1,077,342 
        Total costs and expenses         4,672,097      4,042,763 
        Loss from operations            (3,669,535)    (2,996,507)
  Interest expense                             --        (138,482)
  Interest income and other, net            90,486        222,132 
        Net loss                     $  (3,579,049)  $ (2,912,857)

  Net loss per common and common 
      equivalent share                 $     (1.25)   $     (1.25)

  Weighted average shares 
      outstanding                        2,856,431      2,332,283 





                                                         DRAFT 3/28/97

      The following table is included as an aid to understanding the
  Company's operating results.  The table sets forth the percentages
  which each item bears to revenues and the percentage change in
  dollar amounts from year to year.

                                      Year to Year         Percentage
                                        Percentage           Increase
                          Relationship to Revenues         (Decrease)
                                      % of    % of      Year     Year
                                  Revenues   Revs.     Ended    Ended
  Account Name                        1996    1995      1996     1995

  Revenues                           100%     36%       (4)%    (41% 
  Cost and Expenses
    Cost of goods sold               84 %     19%        23%    (32)%
    Selling, general and 
      administrative                 234%    (11)%        3%    128% 
    Research and 
      development                    148%       8%        38%    135% 
      Total costs and 
        expenses                     466%       3%        16%     64% 
  Loss from operations              (366)%   (37)%        22%   345% 
  Interest expense                    (0)%   716%      (100)%   (27)%
  Interest income and 
      other, net                       9%      0%        59%    n/a  

  Net loss                          (357)%   (21)%        23%   238% 



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission